Antecedentes: El esófago de Barrett (EB) es una entidad con una progresión histológica a malignidad conocida. Los factores de crecimiento insulínico (IGF, de insulin-like growth factor) están involucrados en la carcinogénesis asociada a la obesidad y se han asociado con el riesgo de padecer algunos tipos de cáncer. Objetivos: Evaluar los niveles serológicos de IGF-1 e IGFBP-3 en pacientes con EB y adenocarcinoma de esófago. Pacientes y métodos: Estudio prospectivo de pacientes con EB y adenocarcinoma de esófago explorados con gastroscopia entre septiembre 2012 y diciembre 2015 a los que se realizó una extracción de sangre para la determinación de IGF-1 e IGFBP-3. Se incluyó un grupo control. Resultados: Se incluyeron 116 pacientes: 36 controles, 62 con EB (42 sin displasia y 20 con displasia) y 18 con adenocarcinoma. El IGF-1 y la ratio molar IGF-1/IGFBP-3 presentaron un aumento progresivo en los grupos con EB y adenocarcinoma comparado con los controles (IGF-1: 135,55±66,07ng/ml; 148,33±81,5ng/ml; 108,19±46,69ng/ml, respectivamente; p=0,049) (ratio molar: 0,23±0,91; 0,29±0,11; 0,19±0,06, respectivamente; p=0,001), sin diferencias entre los diferentes grados histológicos. Cincuenta y cuatro de los 65 pacientes con EB fueron seguidos durante una mediana de 58,50 meses (12-113) y 11 de ellos (20,4%) presentaron progresión a displasia de bajo grado (n=8) o displasia de alto grado/adenocarcinoma (n=3), sin encontrar diferencias en el sistema IGF comparado con los que no progresaron. Conclusiones: Los pacientes con EB y adenocarcinoma esofágico presentan cambios en el sistema IGF aunque los niveles de IGF-1 e IGFBP-3 no se correlacionan con la progresión histológica del EB.(AU)
Background: Barrett's esophagus (BE) is an entity with a known histological progression to malignancy. The insulin-like growth factor (IGF) system is involved in the carcinogenesis through obesity-related mechanisms that include IGF and it has been associated with several types of cancer. Objectives: To evaluate the serological levels of IGF-1 and IGFBP-3 in patients with BE and esophageal adenocarcinoma. Patients and methods: Prospective study of patients with BE and esophageal adenocarcinoma who underwent upper endoscopy between September 2012 and December 2015. A baseline determination of IGF-1 and IGFBP-3 was performed. We included a control group of patients without BE. Results: One hundred sixteen patients were included: 36 controls, 62 with BE (42 without dysplasia and 20 with dysplasia) and 18 with adenocarcinoma. IGF-1 and IGF-1/IGFBP-3 molar ratio showed a progression to high levels in BE and adenocarcinoma than in controls (IGF-1: 135.55±66.07ng/ml, 148.33±81.5ng/ml, 108.19±46.69ng/ml, respectively; P=.049) (molar ratio: 0.23±0.91, 0.29±0.11, 0.19±0.06, respectively; P=.001), without differences between the histological types of BE. Fifty-four out of the 65 patients with BE were followed up (median of 58.50 months, range 12113) and 11 of them (20.4%) presented progression to low-grade dysplasia (n=8) or high-grade dysplasia/adenocarcinoma (n=3), without differences in the IGF system compared with patients without progression. Conclusions: Patients with BE and esophageal adenocarcinoma have changes in the IGF system although the serological levels of IGF-1 and IGFBP-3 do not correlate with histological progression of BE.(AU)
Humans , Barrett Esophagus , Adenocarcinoma , Esophagus , Insulin-Like Growth Factor Binding Protein 3 , Insulin-Like Growth Factor I , Longitudinal Studies , Prospective Studies
Endoscopic findings in primary or secondary intestinal lymphoma are non-specific, which can lead to finding a polyp, an ulcer or a completely normal mucosa. As a matter of fact, this makes having a high clinical suspicion with only the endoscopic technique, quite difficult. Due to this reason, we believe that either taking random biopsies or biopsies from visible lesions of affected sections in another imaging tests, should be indicated in order to increase the diagnostic capacity of the endoscopic technique.
Lymphoma, Non-Hodgkin , Lymphoma , Humans , Lymphoma, Non-Hodgkin/diagnostic imaging , Biopsy , Endoscopy , Cecum/pathology
BACKGROUND: Barrett's esophagus (BE) is an entity with a known histological progression to malignancy. The insulin-like growth factor (IGF) system is involved in the carcinogenesis through obesity-related mechanisms that include IGF and it has been associated with several types of cancer. OBJECTIVES: To evaluate the serological levels of IGF-1 and IGFBP-3 in patients with BE and esophageal adenocarcinoma. PATIENTS AND METHODS: Prospective study of patients with BE and esophageal adenocarcinoma who underwent upper endoscopy between September 2012 and December 2015. A baseline determination of IGF-1 and IGFBP-3 was performed. We included a control group of patients without BE. RESULTS: One hundred sixteen patients were included: 36 controls, 62 with BE (42 without dysplasia and 20 with dysplasia) and 18 with adenocarcinoma. IGF-1 and IGF-1/IGFBP-3 molar ratio showed a progression to high levels in BE and adenocarcinoma than in controls (IGF-1: 135.55±66.07ng/ml, 148.33±81.5ng/ml, 108.19±46.69ng/ml, respectively; P=.049) (molar ratio: 0.23±0.91, 0.29±0.11, 0.19±0.06, respectively; P=.001), without differences between the histological types of BE. Fifty-four out of the 65 patients with BE were followed up (median of 58.50 months, range 12-113) and 11 of them (20.4%) presented progression to low-grade dysplasia (n=8) or high-grade dysplasia/adenocarcinoma (n=3), without differences in the IGF system compared with patients without progression. CONCLUSIONS: Patients with BE and esophageal adenocarcinoma have changes in the IGF system although the serological levels of IGF-1 and IGFBP-3 do not correlate with histological progression of BE.
Adenocarcinoma , Barrett Esophagus , Esophageal Neoplasms , Humans , Barrett Esophagus/metabolism , Barrett Esophagus/pathology , Longitudinal Studies , Insulin-Like Growth Factor Binding Protein 3 , Insulin-Like Growth Factor I/metabolism , Prospective Studies , Disease Progression , Esophageal Neoplasms/pathology , Adenocarcinoma/pathology
Background and study aims In contrast with the European Society of Gastrointestinal Endoscopy (ESGE) 2013 and the US Multi-society Task Force (USMSTF) 2020 guidelines, the ESGE 2020 guideline considers patients with three to four adenomasâ<â10âmm or an adenoma with villous histology as low risk. The aim of this study was to quantify the influence of the application of the new ESGE 2020 guidelines, as opposed to the ESGE 2013 and USMSTF 2020 guidelines, on the number of scheduled colonoscopies, and to describe the main causes for changes in the surveillance intervals. Patients and methods A retrospective evaluation was conducted of a prospectively maintained fecal immunochemical test (FIT)-based regional colorectal cancer screening program database. Surveillance regimens following ESGE 2020, ESGE 2013, and USMSTF 2020 guidelines were compared. Results Overall, 1284 individuals with a positive FIT and undergoing colonoscopy were consecutively included. When applying the ESGE 2020 guidelines, 10.8â% of patients changed to a "no-surveillance" group (relative reduction in colonoscopies of 82.5â%). The main reason for these changes was considering three to four adenomas as low risk. The proportion of patients from the "3-year surveillance" group who moved to the "no-surveillance" group was lower when a sessile serrated lesion (SSL) was present (ESGE 2013, 32.0% vs 16.3â%; USMSTF 2020 17.2â% vs 6.8â%). Analyzing the 41 patients with SSLs who remained unchanged in the "no-surveillance" group, only in 15 (36.6â%) the cause was the presence of an SSL. Conclusions applying the new ESGE 2020 guidelines could reduce by 11â% the proportion of individuals being offered surveillance. SLLs have not a major influence on the change of surveillance intervals.
We report the case of a 61-year-old woman having corticoid treatment with corticosteroids for polyarthralgia, who underwent a post-polypectomy surveillance colonoscopy, identifying a 5-mm diameter, flat-elevated polyp in the proximal transverse colon (Paris 0-IIa).
Colonic Polyps , Colon/pathology , Colonic Polyps/complications , Colonic Polyps/pathology , Colonic Polyps/surgery , Colonoscopy , Female , Humans , Middle Aged
El diagnóstico asistido por computador (DAC) constituye una herramienta con gran potencial para ayudar a los endoscopistas en las tareas de detección y clasificación histológica de los pólipos colorrectales. En los últimos años se han descrito diferentes tecnologías y ha aumentado la evidencia sobre su potencial utilidad, lo que ha generado grandes expectativas en las sociedades científicas. Sin embargo, la mayoría de estos trabajos son retrospectivos y utilizan imágenes de diferente calidad y características que son analizadas off-line. En esta revisión se pretende familiarizar a los gastroenterólogos con los métodos computacionales y las particularidades de la imagen endoscópica con impacto en el análisis del procesamiento de imágenes. Finalmente, se exponen las bases de datos de imágenes disponibles de forma pública que son necesarias para poder comparar y confirmar los resultados obtenidos con diferentes métodos
Computer-aided diagnosis (CAD) is a tool with great potential to help endoscopists in the tasks of detecting and histologically classifying colorectal polyps. In recent years, different technologies have been described and their potential utility has been increasingly evidenced, which has generated great expectations among scientific societies. However, most of these works are retrospective and use images of different quality and characteristics which are analysed off line. This review aims to familiarise gastroenterologists with computational methods and the particularities of endoscopic imaging, which have an impact on image processing analysis. Finally, the publicly available image databases, needed to compare and confirm the results obtained with different methods, are presented
Humans , Polyps/classification , Polyps/diagnostic imaging , Colonography, Computed Tomographic/methods , Diagnosis, Computer-Assisted/methods , Artificial Intelligence
Computer-aided diagnosis (CAD) is a tool with great potential to help endoscopists in the tasks of detecting and histologically classifying colorectal polyps. In recent years, different technologies have been described and their potential utility has been increasingly evidenced, which has generated great expectations among scientific societies. However, most of these works are retrospective and use images of different quality and characteristics which are analysed off line. This review aims to familiarise gastroenterologists with computational methods and the particularities of endoscopic imaging, which have an impact on image processing analysis. Finally, the publicly available image databases, needed to compare and confirm the results obtained with different methods, are presented.
Colonic Polyps/diagnostic imaging , Colonoscopy/methods , Diagnosis, Computer-Assisted/methods , Colonic Polyps/pathology , Databases, Factual , Humans , Machine Learning , Reproducibility of Results
BACKGROUND & AIMS: Guidelines recommend routine antibiotic prophylaxis for patients undergoing endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) of pancreatic cysts, but there is conflicting evidence for its necessity. We investigated whether performing the procedure without antimicrobial prophylaxis increases the incidence of infection. METHODS: We performed a multicenter, randomized, noninferiority trial to compare prophylaxis with ciprofloxacin vs placebo in patients with a pancreatic cyst requiring EUS-FNA at multiple centers in Spain. From September 2014 to June 2018, patients were randomly assigned to groups that received the prophylaxis with ciprofloxacin (n = 112) or saline solution (n = 114, placebo). We recorded patients' demographic data, lesion characteristics, and procedure data and followed patients for 21 days. A total of 205 patients completed the trial (90.7%), receiving ciprofloxacin or the control, with no statistically significant differences in demographics, baseline data, or procedure characteristics between groups. The primary outcome was FNA-related infection. Secondary outcomes were incidence of fever, procedure complications, and medication-related adverse events. RESULTS: The only case of FNA-related infection (0.44%) occurred in a patient in the placebo group (0.87%); this patient developed acute pancreatitis and bacteremia after the procedure. Prevention of infection was not inferior in the control group; the difference between proportions was 0.87% (95% confidence interval, -0.84% to 2.59%). There were no differences between groups in fever (2 patients in each group: 1.78% vs 1.76%; P = 1.00) or other adverse events. CONCLUSIONS: In a randomized trial of patients undergoing EUS-FNA for pancreatic cyst evaluation, we found the risk of infection to be low. The incidence of infections did not differ significantly with vs without ciprofloxacin prophylaxis. (ClinicalTrials.gov, Number: NCT02261896).
Anti-Bacterial Agents/administration & dosage , Antibiotic Prophylaxis/standards , Endoscopic Ultrasound-Guided Fine Needle Aspiration/adverse effects , Pancreatic Cyst/diagnosis , Postoperative Complications/prevention & control , Preoperative Care/standards , Aged , Ciprofloxacin/administration & dosage , Female , Humans , Incidence , Male , Middle Aged , Pancreas/diagnostic imaging , Pancreas/pathology , Pancreatic Cyst/pathology , Placebos/administration & dosage , Postoperative Complications/epidemiology , Postoperative Complications/microbiology , Practice Guidelines as Topic , Preoperative Care/methods , Spain
Introducción: A pesar de los avances en las técnicas de imagen, en muchos casos son insuficientes para establecer el diagnóstico de las lesiones quísticas pancreáticas (LQP). Son escasas las publicaciones en nuestro medio que evalúan la combinación de varios métodos obtenidos mediante la punción aspirativa con aguja fina con ultrasonografía endoscópica (USE-PAAF). El objetivo del estudio fue evaluar la utilidad global de la USE-PAAF en el diagnóstico de las LQP. Material y métodos: Estudio retrospectivo a partir de una base de datos actualizada prospectivamente de una cohorte de pacientes remitidos para USE-PAAF por LQP. Se estudió la sensibilidad, la especificidad, el rendimiento diagnóstico del antígeno carcinoembrionario (CEA), la citología y la viscosidad para detectar lesiones mucinosas. Resultados: Desde noviembre de 2013 a abril del 2018 se realizaron 122 USE por LQP. Se realizó USE-PAAF en 94/122 (77%) y se intervinieron 21/122 (17,2%) pacientes. Se incluyeron 33/122 pacientes que tuvieron confirmación diagnóstica mediante histología, imagen (quiste seroso con patrón típico) o evolución clínica. El estudio de la curva ROC determinó el punto de corte ≥419ng/ml para diferenciar lesión quística mucinosa/no mucinosa. El rendimiento diagnóstico del CEA fue del 87,5% (21/24), de la citología del 81,8% (27/33) y de la viscosidad del 84,4% (27/32). Los 3 parámetros en combinación obtuvieron el mejor resultado (30/33, 90,9%). Conclusión: La combinación del análisis del CEA, la citología y la viscosidad del líquido pancreático obtenido mediante USE-PAAF aumenta el rendimiento en el diagnóstico de las lesiones quísticas pancreáticas mucinosas, siendo superior al 90%
Introduction: Despite advances in imaging techniques, in many cases they are insufficient to establish the diagnosis of pancreatic cystic lesions (PCL). There are few publications in our setting that evaluate the combination of several methods obtained by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). The aim of the study was to evaluate the overall utility of EUS-FNA in the diagnosis of PCL. Material and methods: Retrospective study based on a database updated prospectively of a cohort of patients referred for EUS-FNA due to PCL detected in an imaging test. The sensitivity, specificity and diagnostic yield of carcinoembryonic antigen (CEA), cytology and viscosity were studied to detect mucinous lesions. Results: From November 2013 to April 2018, 122 EUS were performed for PCL. EUS-FNA was performed in 94/122 (77%) and 21/122 (17.2%) patients were operated on. We included 33/122 patients who had diagnostic confirmation by histology, imaging (serous cyst with typical pattern) or clinical evolution. The study of the ROC curve determined the cutoff point ≥419 ng/ml to differentiate mucinous/non-mucinous cystic lesions. The diagnostic yield of CEA was 87.5% (21/24), cytology 81.8% (27/33) and viscosity 84.4% (27/32). The three parameters in combination obtained the best result (30/33, 90.9%). Conclusion: The combination of CEA analysis, cytology and viscosity of pancreatic fluid obtained by EUS-FNA increases the performance in the diagnosis of mucinous pancreatic cystic lesions, with it being greater than 90%
Humans , Male , Female , Adult , Middle Aged , Aged , Pancreatic Cyst/diagnostic imaging , Pancreatic Neoplasms/diagnosis , Cohort Studies , Carcinoembryonic Antigen/administration & dosage , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Pancreatic Cyst/pathology , Retrospective Studies , Sensitivity and Specificity , Neoplasms, Cystic, Mucinous, and Serous/diagnosis , ROC Curve , Endosonography
El cáncer colorrectal constituye un problema de salud importante. Se ha demostrado una mejoría de la supervivencia mediante la realización de colonoscopias de cribado y la extirpación de sus lesiones precursoras, los pólipos. Sin embargo, la colonoscopia no es infalible y se han propuesto múltiples estrategias dirigidas a mejorar la calidad de la misma. En esta revisión se describen los sistemas endoscópicos de que disponemos para mejorar la detección y caracterización de los pólipos, las diferentes clasificaciones utilizadas para la predicción histológica y las indicaciones actuales de las técnicas de diagnóstico endoscópico avanzado
Colorectal cancer is a major health problem. An improvement to its survival has been demonstrated by performing colonoscopy screenings and removing its precursor lesions: polyps. However, colonoscopy is not infallible and multiple strategies have been proposed aimed at improving the quality thereof. This report describes the endoscopic systems available to improve the detection and characterization of polyps, the different classifications for histological prediction and the current indications of advanced endoscopic diagnostic techniques
Humans , Colonic Polyps/diagnosis , Colonoscopes , Colonoscopy/instrumentation , Colorectal Neoplasms/diagnosis , Early Detection of Cancer/instrumentation , Adenoma/diagnosis , Equipment Design
Colorectal cancer is a major health problem. An improvement to its survival has been demonstrated by performing colonoscopy screenings and removing its precursor lesions: polyps. However, colonoscopy is not infallible and multiple strategies have been proposed aimed at improving the quality thereof. This report describes the endoscopic systems available to improve the detection and characterization of polyps, the different classifications for histological prediction and the current indications of advanced endoscopic diagnostic techniques.
Colonic Polyps/diagnostic imaging , Colonoscopes/standards , Colonoscopy/methods , Intestinal Polyps/diagnostic imaging , Precancerous Conditions/diagnostic imaging , Rectal Diseases/diagnostic imaging , Colonoscopy/instrumentation , Colorectal Neoplasms/diagnostic imaging , Equipment Design , Humans , Intestinal Polyps/classification
INTRODUCTION: Despite advances in imaging techniques, in many cases they are insufficient to establish the diagnosis of pancreatic cystic lesions (PCL). There are few publications in our setting that evaluate the combination of several methods obtained by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). The aim of the study was to evaluate the overall utility of EUS-FNA in the diagnosis of PCL. MATERIAL AND METHODS: Retrospective study based on a database updated prospectively of a cohort of patients referred for EUS-FNA due to PCL detected in an imaging test. The sensitivity, specificity and diagnostic yield of carcinoembryonic antigen (CEA), cytology and viscosity were studied to detect mucinous lesions. RESULTS: From November 2013 to April 2018, 122 EUS were performed for PCL. EUS-FNA was performed in 94/122 (77%) and 21/122 (17.2%) patients were operated on. We included 33/122 patients who had diagnostic confirmation by histology, imaging (serous cyst with typical pattern) or clinical evolution. The study of the ROC curve determined the cutoff point ≥419 ng/ml to differentiate mucinous/non-mucinous cystic lesions. The diagnostic yield of CEA was 87.5% (21/24), cytology 81.8% (27/33) and viscosity 84.4% (27/32). The three parameters in combination obtained the best result (30/33, 90.9%). CONCLUSION: The combination of CEA analysis, cytology and viscosity of pancreatic fluid obtained by EUS-FNA increases the performance in the diagnosis of mucinous pancreatic cystic lesions, with it being greater than 90%.
Endoscopic Ultrasound-Guided Fine Needle Aspiration , Pancreatic Cyst/pathology , Adult , Aged , Biomarkers/analysis , Carcinoembryonic Antigen/analysis , Carcinoma, Pancreatic Ductal/blood , Carcinoma, Pancreatic Ductal/diagnostic imaging , Carcinoma, Pancreatic Ductal/pathology , Cohort Studies , Endoscopic Ultrasound-Guided Fine Needle Aspiration/statistics & numerical data , Female , GPI-Linked Proteins/analysis , Humans , Male , Middle Aged , Mucins/chemistry , Pancreatic Cyst/blood , Pancreatic Cyst/diagnostic imaging , Pancreatic Cyst/surgery , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/pathology , ROC Curve , Retrospective Studies , Sensitivity and Specificity , Viscosity
We present the case of a 76-year-old male who underwent arthrodesis due to a C7 fracture, which was complicated by an esophageal perforation and required primary surgical closure.
Cervical Vertebrae/injuries , Esophageal Perforation/diagnostic imaging , Spinal Fractures/surgery , Spinal Fusion/adverse effects , Aged , Cervical Vertebrae/diagnostic imaging , Esophageal Perforation/etiology , Esophagus/diagnostic imaging , Foreign Bodies/complications , Foreign Bodies/diagnostic imaging , Gastroscopy , Humans , Male , Spinal Fractures/diagnostic imaging , Tomography, X-Ray Computed
Most extrahepatic cholangiocarcinomas are unresectable at the time of diagnosis and even in case of a resectable cancer, surgery is not an option for the elderly or patients with comorbidities (1). Current treatment alternatives in these scenarios are very limited. Biliary stenting with self-expanding metal stents (SEMS) is the mainstay palliative treatment for biliary obstruction (2). However, emerging experience with endoscopic RF ablation (RFA) in this setting has been reported in the literature
No disponible
Humans , Male , Adult , Radiofrequency Ablation/methods , Angioplasty/methods , Bile Duct Neoplasms/surgery , Cholangiocarcinoma/surgery , Liver Cirrhosis, Biliary/complications , Treatment Outcome
Most extrahepatic cholangiocarcinomas are unresectable at the time of diagnosis and even in case of a resectable cancer, surgery is not an option for the elderly or patients with comorbidities (1). Current treatment alternatives in these scenarios are very limited. Biliary stenting with self-expanding metal stents (SEMS) is the mainstay palliative treatment for biliary obstruction (2). However, emerging experience with endoscopic RF ablation (RFA) in this setting has been reported in the literature.
Bile Duct Neoplasms/surgery , Catheter Ablation/methods , Cholangiocarcinoma/surgery , Adult , Bile Duct Neoplasms/diagnostic imaging , Cholangiocarcinoma/diagnostic imaging , Cholangiopancreatography, Endoscopic Retrograde , Humans , Hypertension, Portal/therapy , Male , Radiofrequency Ablation/methods
Adenocarcinoma/secondary , Liver Neoplasms/secondary , Liver Transplantation , Lymph Nodes/diagnostic imaging , Prostatic Neoplasms/pathology , Tissue Donors , Adenocarcinoma/diagnostic imaging , Endosonography , Esophagoscopy , Humans , Lymph Nodes/pathology , Lymphadenopathy/diagnostic imaging , Lymphadenopathy/pathology , Lymphatic Metastasis , Male , Middle Aged
La endoscopia digestiva es la herramienta más efectiva en el diagnóstico de muchas enfermedades del tracto digestivo y constituye una parte esencial en la formación de un médico interno residente (MIR) de Aparato Digestivo. La Sociedad Española de Endoscopia Digestiva (SEED), conocedora de todos los avances técnicos acontecidos en los últimos años, cree necesario definir un programa de competencias que deben adquirir los especialistas de aparato digestivo en formación durante su residencia. En este artículo se describen los objetivos de la formación en endoscopia, las técnicas que se deben conocer y las habilidades que se deben adquirir tanto en diagnóstico como en terapéutica. Finalmente, se propone un modelo para la evaluación de competencias
Digestive endoscopy is the most effective tool available for the diagnosis of multiple gastrointestinal (GI) tract conditions, and it represents a key aspect in the training of gastroenterology residents according to the Spanish MIR (médico interno residente) program. The Sociedad Española de Endoscopia Digestiva (SEED), aware of all the technical advances that have emerged during the past few years, deems it necessary to define a program of the skills specialists-in-training in gastroenterology should acquire during their residency. This paper describes the goals of endoscopy training, the techniques that should be mastered, and the diagnostic and therapeutic skills this specialty requires. Finally, a model is suggested for the assessment of competence
Humans , Endoscopy, Gastrointestinal/education , Gastrointestinal Diseases/diagnosis , Curriculum/trends , Spain , Professional Competence , Internship and Residency/trends , Professional Training , Educational Measurement
